A larger sample size (well matched for all genotypes, sex and age) and longitudinal study design focusing on the neuropathological staging of disease will be needed to elucidate the specific effect of APOE on the sequelae of cerebrovascular dysfunction in AD pathobiology. This evidence concerns the gene APOE and Alzheimer disease.